A B S T R A C T Although numerous agents have been shown experimentally to protect ischemic myocardium, a critical unanswered question is whether function is preserved in the salvaged tissue. Accordingly, 38 openchest dogs had measurements of percent segment length shortening (%SS) and velocity of segment length shortening either in midmyocardial or subepicardial and subendocardial ischemic segments before and after 60 min of left anterior descending coronary artery occlusion during 5 h of reperfusion; 10 additional dogs were subjected to 3 h of coronary occlusion followed by 72 h ofreperfusion. 15 min after coronary artery occlusion, radiolabeled microspheres were injected into the left atrium for measurement of regional myocardial blood flow, and dogs were treated with 1 mg/kg i.v. (n = 23) of an anti-inflammatory drug, flurbiprofen or an equal volume of saline (n = 25). The ischemic myocardiumat-risk for necrosis was determined by injecting methylene blue dye into the left atrium with the coronary artery reoccluded at the end of the reperfusion period, slicing the left ventricle into thin transverse sections, and measuring the areas of each slice that were not perfused (pink unstained tissue) by methylene blue. The quantity of necrotic tissue in each transverse section was measured by planimetry after incubation ofthe slices in triphenyltetrazolium chloride, and by direct histological examination in dogs with 72 h of reperfusion.
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Regional myocardial blood flow of the ischemic segments between the ultrasonic dimension crystals was similar in treated (0.34+0.03 ml/min per g) and control dogs (0.35+0.03 ml/min per g). In saline-treated control dogs subjected to a 1-h coronary occlusion, Dr. Darsee is a recipient of a National Research Service Award from the National Heart, Lung, and Blood Institute, National Institutes of Health. Received for publication 23 May 1980 and in revised form 23 February 1981. 17 .9+1.8% of the myocardium-at-risk became necrotic. but in flurbiprofen-treated dogs none of the tissue became necrotic. In saline-treated dogs passive lengthening of the previously ischemic segments persisted through 5 h of reperfusion in all three regions of myocardium after a 1-h coronary occlusion. In flurbiprofen-treated dogs regional function returned to normal within 5 min of reperfusion in both the subendocardium (%SS preocclusion = 17.2±2.0%; 5 min reperfusion = 17.8+3.1%; P = NS) and in the midmyocardium (%SS preocclusion = 17.8±+2.2%; 5 min reperfusion = 17.9+2.3%; P = NS) and was not significantly different after 5 h of reperfusion from what it was before coronary occlusion. In the subepicardium oftreated dogs regional function began to improve within 15 min of drug administration even during coronary occlusion. Regional function was not different from preocclusion values after either 5 min or 5 h of reperfusion (%SS preocclusion = 21.0±2.4%; 5 min reperfusion = 20.6 ±+3.8%; P = NS). In dogs subjected to 3 h of coronary occlusion and 72 h of reperfusion, the administration of flurbiprofen was also associated with significantly smaller infarcts and a significantly more rapid rate of functional recovery than in control dogs.
Thus, it appears that flurbiprofen not only decreased the quantity of necrosis in tissue made ischemic after coronary occlusion and then reperfused, but also allowed more rapid recovery of segmental function in ischemic but nonnecrotic tissue and in tissue with patchy necrosis; such recovery did not occur in equally ischemic myocardium in untreated control dogs. Earlier functional recovery of reversibly injured tissue following prolonged periods of ischemia is an additional important role for agents that protect ischemic myocardium from necrosis. INTRODUCTION Previous investigations have shown that numerous interventions can potentially prevent or reduce the number and severity ofdangerous arrhythmias originating in ischemic myocardium (1, 2) , and that other agents limit the extent of necrosis following experimental coronary occlusion (3, 4) . Although it seems inherently beneficial to salvage some of the ischemic myocardium-at-risk from proceeding to the stage of necrosis, thereby decreasing the percentage of left ventricular tissue involved in the infarct, it is unknown whether the salvaged tissue functions normally and contributes to the overall performance of the left ventricle. It is possible that although the salvaged tissue does not become necrotic by histologic criteria, its function may remain impaired and it either may act as a stiff, noncontracting segment or may continue to undergo passive lengthening, in either case impairing overall ventricular function.
The time-course of functional recovery ofmyocardial tissue following coronary occlusion has been studied in the conscious dog (5-7) and in patients with clinically documented myocardial infarction in the absence of any intervention (8, 9) . These investigations have shown that the rate ofrecovery ofthe marginal ischemic tissue is extremely slow. It would be important to determine whether ischemic tissue salvaged by an intervention recovers contractile function, and if so, how rapidly. If the salvaged ischemic tissue is capable of contributing to overall ventricular performance, myocardial protection would have even greater importance than heretofore considered. The present study was undertaken to determine whether flurbiprofen, an agent shown previously to be capable of salvaging myocardium-at-risk of developing necrosis as a consequence of a sustained coronary occlusion (10) , also preserves the functional characteristics of the salvaged tissue. Ultrasonic crystals were placed in the myocardium for measuring instantaneous myocardial segment length according to the following method. First, the LAD coronary artery was briefly occluded in order to determine the epicardial region of reduced blood flow. This was accomplished by injecting a 4% solution of sodium fluorescein (0.5 ml/kg) into the left atrium; this results in a nonfluorescent region of epicardium perfused by the occluded coronary artery when an ultraviolet light (340 nm) is used to illuminate the heart. We have previously shown that the tissue that is not perfused by fluorescein using this technique has values for regional myocardial blood flow (RMBF) of <0.4 ml/min per g (10) . The border between fluorescent and nonfluorescent epicardium was outlined by painting a thin line of gentian violet over the line of demarcation, before the fluorescein was completely washed out of the myocardial capillaries. A pair of ultrasonic dimension crystals was implanted in the region of the left ventricular equator at the midmyocardial level in 34 dogs and one pair in the subendocardium and one in the subepicardium in the remaining 22 dogs. The midmyocardial depth was chosen for most ofthe experiments since we wished to analyze the function of tissue that remains ischemic for a prolonged period but does not become infarcted. Previous experiments in our laboratory have shown that infarction does not usually extend outward as far as the midmyocardium after a 1-h coronary occlusion followed by reperfusion (11) . One of the crystals was positioned at the ischemic border as outlined above and the other -10 mm within the ischemic zone on an approximate equatorial relationship with the first crystal (Fig. 1) immiii/s. To be al)le to accouniit f'or possil)le miiierosplhere "wkvashout" in infarcted tissue, -2.0 x 10" radioactive microspheres (8) (9) (10) gnm Diamii) labeled wvith 46Sc were injected into the left atriumii just before coronary occlusion in the 12 dogs to be subjected to 3 h of coronary occlusion followed by 72 h of reperfusion. The LAD coroncary artery was clamped with a vascular clip distal to the coronary flowprobe. Any dog having one or more episodes of ventricular fibrillation (always within the first 15 min after coronary, occlusion) was excluded from further study. 15 mill after LAD coronary occlusion, RNMBF was determined 1y injecting -2.0 x 106 radioactive microspheres (8-10 uxm Diam) labeled with 141 Ce into the left atriumii. Dogs randomized to the treated group received 1 mg/kg flurbiprofen intravenously and conitrol dogs received 1 ml/kg saline.
METHODS
Flurbiprofen is a potent anti-inflamimatory ageint that inhiibits the enzyme cvclooxvgenase, aind thlus the subsequent production of enidoperoxides anid prostaglanidins PGE2 aind PGF2a, which participate in the inflaimmatory process. It also appears to interfere wvith the kinin and histamine systems, stabilize lvsosomnal membranes, suppress leukocvte motility anid phagocvtosis, and interfere with platelet aggregationi (10) .
50 min after coronary occlusion in the dogs subjected to a 1-h coronary occlusion, lidocaine (1.5 mg/kg) was adminiisteredl intravenouslyr to suppress the development of reperfusioni arrhythimias. 60 min after coronary occlusioni in this subgroup of clogs, the clamiip was removed and reperfusion was allowed to occur. We used a model in which reperfuisioni was allowed after 60 min in some of the dogs becacuse of its clinical relevanice to patients who are canididates f'or acuite mv-ocardcial reascutilarizationi or intracoronarv fibrinolvsin adminiistrationi (13) , and becautse we wislhed to analyN-ze the function of tissue in which no necrosis had occurred.
In the remaininig dogs operated under sterile conditions, the coronary clamp was removed after 3 h of coronarv occlusion; the leads from the ultrasoniie crystals, the pressure gauige, anid the coronary flowprobe were tunnllele(d suibcutaneou sly anid exteriorized between the scapuilae; aind the thoracotomvy \w,,as closed in layers.
Any dog having one or more episo(les of' ventrictlar taclhcardcia lastinig > 5 s or ventrictular fibrillation dutrinig reperfusion was also excluded from the study. Recordings of hemodynamic variables at paper speeds of 25 and 100 mm/s were miiadle everyiminute during the first 10 mnin ofreperfusion, everv 5 min for the next 50 min, aind then hourly for 5 h. In the dogs subjected to 3 h of coronarv occlusion, hemodyniaic Xivariables were also recor(led everv 12 h for 72 h. Either 6 or 75 h after coronary occlusion the dogs received a second injectioni into the left atriumii of microspheres labeled \vith '13Sn with the LAD coronary artery patenit. This wvas done to determine whether R.MBF during reperfusioin was similar in the ivyocardial tissue between the ultrasonic crystals in treated and control dogs, and wvhether flurbiprofen had an influence on RMBF in the entire ischemic bed during reflow. Following microsphere injection, all dogs received a 30-s infusion of methylenie blue (not pH-dependent), 3 to provide a visual demarcation between the nonperfused myocardial tissue distal to the coronary clamp and the perfused tissue supplied by unoccluded vascular beds. Ventricular fibrillation or standstill was then induced by an overdose of barbiturate and the hearts were excised rapidly and placed in ice.
The right ventricle, epicardial fat, valve tissue, and chordae tendineae were cut away and the left atrium and adjoining vascular structures were separated from the left ventricle at the atrioventricular ring. The remaining left ventricle was rapidly frozen in liquid freon and sliced with a rotary blade into transverse sections 5 mm in thickness and allowed to thaw. The section containing the ultrasonic crystals was carefully dissected in order to expose the crystals. The section was photographed and then the thickness of the ventricular wall and the depth of the ultrasonic crystals within the ventricular wall were measured. The relationship between the lateral ultrasonic crystal and the edge of myocardium outlined by the methylene blue border was also recorded.
Clear glass plates were placed over both sides of all left ventricular sections; epicardial and endocardial outlines as well as the areas perfused and not perfused by methylene blue were traced on clear sheets of acetate under a x 10 magnifying lens. To visualize the infarcted tissue the slices were incubated in triphenyltetrazolium chloride (TTC) for 20 min at 37°C (14) . Infarcted (white) and noninfareted (deep red) areas on both sides of each slice were also traced on the acetate sheets. In the dogs subjected to 3 h of coronary occlusion followed by 72 h of reperfusion, two transverse slices from each left ventricle were also divided into -15-mm wide transmural sections, stained with hematoxylin, eosin, and Masson trichrome, and examined microscopically to determine the location and quantity of necrotic tissue. The slides of stained tissue sections were placed in a photographic enlarger and the magnified (-x 50) images of infarcted and noninfarcted tissue were traced as previously described (15) . Necrosis was defined by the presence of clumping and coagulation of the myocardial fibers, pyknosis of the nuclei, obliteration of cross-striations, and more intense eosinophilia than in the nonnecrotic tissue. The following information was obtained by computation using values measured by a computerized electronic planimeter: (a) the areaat-risk for necrosis (Ar = ratio of all areas unstained by methylene bltue to total areas of all slices); and (b) area of necrosis (An = ratio of' all areas unstained by TTC to total areas of all slices, or in dogs subjected to 3 h of coronary occlusion, the ratio of' the area of histologically infarcted tissue to total area). From these values the area of necrosis was expressed as a f'raction of the area-at-risk by dividing An by Ar.
To determine whether the presence of flurbiprofen might possibly alter the staining characteristicsof TTC, five additional dogs were stubjected to 1-h coronary occlusions followed by 5 h of' reperfulsion. The left ventricles were sectioned as described previouisly and the cut surf:aces of' contiguous slices (identical inf:arct areas) were inctubated separately, one in TTC alone, and the other in TTC plus flurbiprofen.
The inf:arct areas were drawn, planimetered, and compared to ascertain whether any diff'erences in the apparent size or staining of' the inf:arcts was present.
Using between the ultrasonic crystals (zone 3) (two strips of tissue were cut in dogs with both subepicardial and subendocardial crystals); (d) methylene-blue stained tissue immediately adjacent to the lateral border of the area-at-risk (zone 4); and (e) normal myocardium distant from the areaat-risk (zone 5). Each of these sections was further divided into inner (subendocardial-half) and outer (subepicardial-half) portions except for the tissue from zone 3, which was left intact. The pieces of tissue were weighed and placed in a multichannel gamma well counter and counted in appropriately selected energy windows for 10 min. Values for RMBF and cardiac output were calculated as previously described (16, 17) . In the dogs subjected to 3 h of coronary occlusion followed by 72 h of reperfusion, the degree of microsphere "washout" after 3 d was assessed by calculating the ratio of RMBF in noninfarcted tissue to RMBF in infarcted tissue as measured by microspheres injected before coronary occlusion (when the ratio should Changes in regional function during reperfusion after 1 h of coronary occlusion Both the rate of recovery of active shortening in the ischemic segments (Fig. 3 ) and the degree of hyperemic coronary flow during reperfusion differed between treated and control groups.
Subendocardial segments. In control dogs systolic passive lengthening of the previously ischemic seg- (Fig. 9) . In fluirbiprof'en-treated dogs subjected to 3 h of coronary occlusion the return of active shortening in the previously ischemic segments occurred at a slower rate than occurred after a 1-h occlusion in treated dogs, but even this slower rate of recovery was significantly different from that in the control group (Fig. 9) . After Changes in global function during reperfusion after 3 h of coronary occlusion
In control dogs the LVEDP was 8.9±1.6 mm Hg at the end of the 3-h coronary occlusion period, increased to 11.7±2.3 mm Hg (P < 0.01, compared with preocclusion value), and remained elevated (10.5 ±2.1 mm Hg; P < 0.01) after 72 h of reperfusion. The value for dPIdt at DP40 was not significantly improved after 72 h of reperfusion (1,652±186 mm Hg/s) when compared with the value at the end of the 3-h period ofcoronary occlusion (1,621+195 mm Hg/s), and was still depressed when compared with the preocclusion value (1,984+ 187 mm Hg/s; P < 0.05).
In flurbiprofen-treated dogs the LVEDP returned to preocclusion value after 72 h of reperfusion (preocclusion = 4.8+0.8 mm Hg; 72 h reperfusion = 5.1 ±0.9 mm Hg; P = NS), representing a significant difference from the control group (P < 0.01, compared with control). The value for dP/dt at DP40 returned to preocclusion value (preocclusion = 1,963±198 mm Hg/s) after 24 h of reperfusion (1,904+200 mm Hg/s) and also represented a significant improvement compared with control (P < 0.01). 
Location of ultrasonic crystals and RMBF
It was deemed important to ascertain whether the placement of the ultrasonic crystals was relatively uniform with respect to both the lateral border of the ischemic bed and the depth within the myocardium, because differences in placement alone could account for variations in segment function. For example, myocardial segments nearer the central region of the ischemic bed or closer to the endocardium might be expected to have lower values for RMBF during coronary occlusion than segments nearer the ischemic border or closer to the subepicardium. It is also possible that the rate of recovery of active shortening during reperfusion would be slower in segments with lower values for RMBF during coronary occlusion. The location of the crystals at postmortem examination, however, was not significantly different between control and treated dogs (in comparisons of similar sites, i.e., midmyocardium with midmyocardium, etc.) with respect to either lateral orientation or transmural depth.
Furthermore, values for RMBF within the ischemic segments of control dogs during 1 h of coronary occlusion (0.33±0.04 ml/min per g) were not different from RMBF values in treated dogs (0.35+0.03 ml/ min per g; P = NS). The values for RMBF in the other four zones were also similar in these two groups of dogs (Table III) . In the same two groups of dogs after 5 h of reperfusion, RMBF in zones 1 through 4 returned to values that were not statistically different from values in normal myocardium (zone 5) except for the endocardial portion of zone 1 in control dogs. Even with 5 h of reperfusion, RMBF increased to an average of only 58% of the value in normal tisstue and was statistically different (P < 0.05) from RMBF in the same region in treated dogs. Because the endocardial portion of zone 1 in control dogs always contained some necrotic tissue, it is likely that the decreased RMBF in this region represents a "no-reflow" phenomenon (11) .
In dogs subjected to 3 h of coronary occlusion, RMBF in the tissue between the subendocardial ultrasonic crystals also was not significantly different between control dogs (0.34+0.04 ml/min per g) and dogs treated with flurbiprofen (0.32+±0.05 ml/min per g; P = NS). After 72 h of reperfusion, RMBF in the tissue in the endocardial portion of zone 1 was only 0.51±0.03 ml/min per g in control dogs and 0.68+0.05 ml/min per g (P < 0.05) in treated dogs, which suggests that a zone of no-reflow was present in both groups, although it was slightly more severe in the control dogs.
MtjocardiallnecCrosis
The quantity of myocardiumi-at-risk expressed as a percentage of total left ventricle was similar in treated (29.2±2.6%) aind control dogs (28.1±2.2%; P = NS) subjected to 1 h of coronary occlusion. In control dogs, however, 17.9±1.8% ofthe myocardium-at-risk became necrotic compared with 0% necrosis in flurbiprofentreated dogs. In control dogs the necrotic tissue occupied the most subendocardial portion of the areaat-risk and in none did it extend to the region between the ultrasonic crystals, and in fact was always at least 3 mm away from the crystal positioned within the ischemic bed (Fig. 10) .
In dogs subjected to 3 h of coronary occlusion, the quantity of myocardium-at-risk was also similar in control (27.2+2.3%) and treated (28.2±2.5%; P = NS) groups. In the control group, 65.3±6.8% of the myocardium-at-risk became necrotic; this was significantly greater (P < 0.01) than in the treated group in which only 36.7±3.5% of the myocardium-at-risk became necrotic. In these two groups of dogs, the amount of necrotic tissue was assessed from wholemount specimens by light microscopy and standard histological criteria, although the values for infarct size as assessed by TTC staining were not significantly different from those obtained by histological examination (Fig. 11) . In control dogs the tissue between the subendocardial ultrasonic crystals was completely infarcted. In treated dogs the same region of tissue showed only "patchy" areas of necrosis which occupied <10% of the region but was impossible to quantify accurately because of its patchy nature. Tissue between the subepicardial crystals was free from infarction in both groups of dogs. In the five additional experiments to determine whether flurbiprofen had any effect on TTC staining, the quantity of necrotic tissue was not significantly different between contiguous surfaces of left ventricular tissue; thus, the differences in infarct size as evaluated by TTC in control and treated dogs sub- jected to 1 h of coronary occlusion were not the result of an alteration in the staining characteristics of TTC induced by flurbiprofen because flurbiprofen had no effect on TTC staining.
DISCUSSION
The extent and distribtution of infarcted mvocardial tissue after coronary occlusion is related to eventual morbidity, mortality, and cardiac functioin in patients with ischemic heart disease (19, 20 (21, 22) . The time at which reperfusion of ischemic tissue occurs, however, is important in determining its ability to matintaini myocardial cell integrity ancl segmeintal myocaardial functioni (11) . Pagani et al. (6) (24) , the combination of propranolol and oubain (25) , hypothermia (26) , nitroglycerin (27) , and nitroprusside (27) . It has also been shown that greater left ventricular wall tension can be developed during reperfusioin in dogs respiring high levels of inspired oxygen during coronary occlusion than in dogs respiring room air (28) . In our study there were no differences in regional function during coronary occlusion in the dogs receiving flurbiprofen aind in control dogs treatted with saliie, except in the subepicardial segmeints of treated dogs, in which there was a retuirn of active shortening even l)efore reperfuision. This may have been duie to the selective availability of the drug to the isclhemiiic subepicardium, which has the highest levels of RMBF during occlusion. Moreover, flurbiprofen itself did not produce any immediate hemodynamic effects or changes in regional myocardial blood flow during occlusion. The differences in regional fuiiction in the subendocardiumn and midmyocardium occurred only during the period of reperfusion. Since reactive hyperemia was Early Recovery of Function in Salvaged AMyocardium greater in flurbiprofen-treated dogs than in control dogs after the release of the coronary occlusion, it seems likely that the rapid recovery of regional function was modulated, at least in part, by RMBF during early reperfusion and therefore by the resistance of the coronary perfusion bed. This difference in the resistance of the perfusion bed in treated dogs could be related to differences in either intravascular (capillary integrity) or extravascular (interstitial edema) factors. The greater reactive hyperemia was not a consequence of the augmented contractile function observed in flurbiprofen-treated dogs during reperfusion, because studies with the coronary bed maximally dilated have shown that myocardial contractility is a major component of extravascular coronary resistance and is a mechanical determinant of regional coronary blood flow and its transmural distribution (29) ; that is, an increase in myocardial contractility during maximal coronary dilatation causes a reduction in blood flow to the same tissue.
Thus, in the present study it appears that flurbiprofen treatment was associated with greater reactive hyperemia and increased regional performance during early reperfusion and that either the increase in RMBF modulated the increased contractile function or both were independently improved. Flurbiprofen appears to inhibit the cellular inflammatory response to ischemia and the production ofcertain inflammationaugmenting prostaglandins, and to decrease platelet aggregation (30) . Although no conclusive evidence is currently available, flurbiprofen may also protect the integrity of the capillary walls in ischemic tissue. The mechanism by which it caused a rapid recovery of regional function during reperfusion is probably a combination of these properties, but appears to be independent of its effect on decreasing infarct size.
The present study lends support to the hypothesis that there are regions of functionally depressed myocardium surrounding irreversibly injured tissue with the potential for recovery of nearly normal contractility if an effective intervention is administered early enough after coronary artery occlusion. Future studies utilizing various interventions to protect ischemic myocardium from necrosis should certainly include an assessment of the preservation of regional ventricular function.
It must be emphasized that coronary occlusions in this study were followed by reperfusion and that the effects of flurbiprofen on the regional performance of ischemic myocardium during permanent coronary occlusions are unknown. However, the 1-and 3-h coronary occlusion models have considerable clinical relevance since many patients are being considered for early saphenous vein bypass graft surgery or intracoronary administration of streptokinase during which the patient may require preliminary myocardial protection for only a few hours (13) . Both these techniques can be offered to the patient only after he or she reaches the hospital, and may be delayed while the necessary preparations are made to ensure that the procedures are carried out as successfully as possible. The observation that the administration of flurbiprofen followed by reperfusion resulted in less myocardial damage and earlier recovery of function than reperfusion alone, suggests that this agent may be used to provide protection as soon as the patient reaches a medical care facility, and during the necessary few hours until myocardial perfusion can be restored. By delaying the progression of myocardial necrosis in severely ischemic tissue, flurbiprofen may allow a greater portion of the heart to be salvaged by reperfusion.
